TinyGemsBreaks Archive - Page 44 of 129

ThursdayDec 21, 2023 4:36 pm

TinyGemsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) Announces Delivery of 38 Class 3s to Randy Marion Automotive Group

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, today announced the delivery of 38 additional Class 3 vehicles to Randy Marion Automotive Group (“RMA” or “Randy Marion”) with the company invoicing RMA for $2.5 million. Randy Marion has committed to 1,000 Class 3 vehicles for a total of $63 million, with the majority of the vehicles to be delivered in calendar year 2024. As previously reported, Class 3 production at Mullen’s Tunica, Mississippi, facility is planned for 150 vehicles for 2023, with total capacity for Class 3 planned at 3,000 vehicles annually per shift. “The Mullen THREE product…

WednesdayDec 20, 2023 3:19 pm

TinyGemsBreaks – Diamond Lake Minerals Inc. (DLMI) CEO Discusses Traditional, Digital Finance in Exclusive Benzinga Interview

Diamond Lake Minerals (OTC: DLMI), a leading multistrategy operating company specializing in the development and support of digital assets and SEC-registered security tokens, was featured in a recent exclusive Benzinga interview. During the interview, Diamond Lake Minerals CEO Brian Esposito talked with host Michael Murry about the company, which specializes in the development and support of digital assets and SEC-registered security tokens. During the interview, Esposito discussed how Diamond Lake Minerals is bridging traditional finance with a digital future. Esposito noted that DLMI is focused on building strong companies with sustainable earnings. “Bu more importantly and what’s making us pretty…

WednesdayDec 20, 2023 1:59 pm

TinyGemsBreaks — Mullen Automotive Inc. (NASDAQ: MULN) Announces ‘Milestone’ Certification for Class 1 EV Cargo Van, EV Now Fully Compliant for Sale Throughout US

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, has reached an EV commercial milestone: its Mullen One, a class 1 EV cargo van, received certification from the California Air Resources Board (“CARB”) as a zero-emission vehicle in the state of California. This certification means that Mullen ONE can be sold in CARB-compliant states, including California, Connecticut, Colorado, Delaware, Maine, Maryland, Massachusetts, New Jersey, New Mexico, New York, Oregon, Pennsylvania, Rhode Island, Vermont and the District of Columbia. Combined with an earlier certification of conformity received last month from the Environmental Protection Agency (“EPA”), the Mullen ONE is in full compliance…

WednesdayDec 20, 2023 1:23 pm

TinyGemsBreaks – GEMXX Corporation (GEMZ) Amends LOI Closing Deadline, Plans Implementation of Pilot Mine on Yukon Gold Property

GEMXX (OTC: GEMZ), a leader in the ammolite gemstone mine-to-market segment, continues to make progress in its assessments quantifying the proven and potential gold resources on the Yukon Gold property. Currently GEMXX is working closely with the project’s current owners to implement a work plan calling for a pilot mine as soon as weather permits in 2024. With that in mind, the company announced that the closing deadline in the original letter of intent (“LOI”) has been extended. The company believes that the project represents a valuable asset and a return on investment (“ROI”) with proven resources of 2.2 million…

WednesdayDec 20, 2023 10:24 am

TinyGemsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Approves Election of Directors During 2023 Annual General Meeting

InMed Pharmaceuticals (NASDAQ: INM), a leader in the pharmaceutical research, development, manufacturing and commercialization of rare cannabinoids and cannabinoid analogs, is reporting on the results of its 2023 annual general meeting. According to the report, during the meeting, which was held on Dec. 19, 2023, all matters considered by shareholders were approved; agenda items were sent to shareholders in a notice of meeting and management information communication that was released on Oct. 27, 2023. In addition, shareholders approved the election of five directors, including Eric A. Adams, Janet Grove, Andrew Hull, Nicole Lemerond and Bryan Baldasare; directors will hold their…

TuesdayDec 19, 2023 1:43 pm

TinyGemsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) to Effect 1-for-100 Reverse Stock Split, CEO Releases Letter to Shareholders

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, announced that it will effect a 1-for-100 reverse stock split of its common stock, par value $0.001 per share. According to the announcement, the stock split will be effective Dec. 21, 2023, at 12:01 a.m. ET. The company’s common stock will continue to trade on the NASDAQ exchange under the existing symbol — MULN — and will begin trading on a split-adjusted basis when the market opens on Dec. 21, 2023. A proposal to authorize the reverse stock split was approved by company stockholders at a Special Meeting of Stockholders; Mullen Automotive’s…

MondayDec 18, 2023 2:37 pm

TinyGemsBreaks – Cepton Inc. (NASDAQ: CPTN) COO Featured in Most Recent Proactive Video Interview Focused on Cost-Efficiency, Strategic Partnerships

Cepton (NASDAQ: CPTN), a Silicon Valley innovator and leader in high-performance lidar solutions, is in the spotlight. Cepton chief commercial officer Mitch Hourtienne is the featured guest on the latest video interview from Proactive. During the segment, Hourtienne and Proactive host Steve Darling talked about the evolution of LiDAR technology, including the fact that in the past decade-plus, the cost of LiDAR has decreased, making the technology more widely accessible. During his comments, Hourtienne explained Cepton’s commitment to cost efficiency, noting the company’s use of a low-cost base material and strategic supplier partnerships. Hourtienne also mentioned that the company opted to…

MondayDec 18, 2023 1:38 pm

TinyGemsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Announces DSMB Recommendation to Continue Pivotal GBM Study without Modification

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, announced a recommendation from the independent Data Safety Monitoring Board (“DSMB”) regarding Berubicin, the company’s investigational agent. According to the announcement, the DSMB recommends that CNS Pharmaceuticals’ ongoing global, potentially pivotal trial of Berubicin for the treatment of glioblastoma multiforme (“GBM”) continue without modification. The company also noted that it anticipated enrollment for the trial to be complete in the first quarter of 2024. The Berubicin study is a multicenter, open-label, randomized controlled study…

MondayDec 18, 2023 10:40 am

TinyGemsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) Announces Adjournment of Special Meeting

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, adjourned its Special Meeting of Stockholders, which convened on Dec. 15, 2023; the meeting is slated to begin today at 9:30 a.m. PT. According to the announcement, the decision to adjourn the meeting was made to provide time to solicit proxies regarding a proposal that had been submitted to stockholders for approval. The company noted that the proposal, Proposal 1, seeks stockholder approval to amend the company’s certificate of incorporation to effect a reverse stock split of MULN’s outstanding common stock at an exchange ratio between 1-for-2 to 1-for-100; the specific…

FridayDec 15, 2023 3:28 pm

TinyGemsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Targeting New and More Lucrative Global Markets

Lexaria Bioscience Corp. (NASDAQ: LEXX), a global innovator in drug delivery platforms, is exploring the impact of its patented DehydraTECH(TM) technology on the oral performance of GLP-1 drugs for the treatment of diabetes and weight loss. “The move could help Lexaria carve out an important market share for an industry that is projected to bring in between $150 billion and $200 billion a year. Given the positive results the company has achieved so far in its diabetes and hypertension clinical studies, Lexaria is optimistic that its foray into GLP-1 drugs will yield positive results and open up its technology to…

Spotlighting undiscovered companies with enormous upside potential.

Contact us: (512) 354-7000

TinyGemsBreaks